If Abbvie’s Allergan gets its way, the biggest threat to its blockbuster wrinkle remover Botox — Evolus’s Jeaveau — will be banned from the U.S. for the next 10 years. Allergan and its Korean partner …
( read original story …)
The SkinCare Site
If Abbvie’s Allergan gets its way, the biggest threat to its blockbuster wrinkle remover Botox — Evolus’s Jeaveau — will be banned from the U.S. for the next 10 years. Allergan and its Korean partner …
( read original story …)